微信在线咨询
| 产品编号 | 产品名称 | 产品包装 | 产品价格 |
| L15890 | MAP3K19基因敲除质粒 | 5µg | 999.00元 |
| L15891 | MAP3K19基因敲除慢病毒 | 10^8 TU | 6999.00元 |
| L15892 | MAP3K19基因敲除HEK293T细胞 | 1支/瓶 | 7999.00元 |
| L15893 | MAP3K19基因敲除HEK293T细胞RIPA裂解液 | 100µg | 1258.00元 |
| L15894 | MAP3K19基因敲除HEK293T细胞Trizol裂解液 | 500µl | 1258.00元 |
MAP3K19 Knockout Lentivirus(MAP3K19基因敲除慢病毒)是一种感染动物细胞后可以同时表达Cas9、目的基因sgRNA和puromycin抗性基因的慢病毒。本产品用于在动物细胞中基于CRISPR/Cas9技术敲除目的基因，并且本慢病毒中sgRNA的有效性已经通过T7EI法的验证。
本慢病毒基因序列的关键图谱信息请参考图1。本慢病毒可用于感染细胞或组织并进行目的基因的CRISPR/Cas9敲除。
图1. 可同时表达sgRNA、Cas9和puromycin抗性的本慢病毒其基因序列的关键图谱信息。
用于包装本慢病毒的质粒中的sgRNA基于碧云天研发的CRISPR/Cas9 sgRNA快速筛选和验证体系获得，sgRNA的有效性已经通过T7EI法验证。
本慢病毒用于实验时，建议同时选购无任何靶向的对照慢病毒Control Knockout Lentivirus (L00015)或靶向GFP的对照慢病毒GFP Knockout Lentivirus (L00017)。
碧云天同时提供基于CRISPR/Cas9技术的MAP3K19基因敲除的质粒(L15890 pLenti-MAP3K19-sgRNA)、慢病毒(L15891 MAP3K19 Knockout Lentivirus)、HEK293T细胞(L15892 MAP3K19 Knockout HEK293T Cells)、HEK293T敲除细胞的RIPA裂解液(L15893 MAP3K19 Knockout HEK293T RIPA Lysate)、HEK293T敲除细胞的Trizol裂解液(L15894 MAP3K19 Knockout HEK293T Trizol Lysate)等产品，具体请在碧云天网站查询或在本产品网页点击相应产品。
MAP3K19基因的基本信息如下：
| Species | Gene Symbol | Gene ID | GenBank Accession | Transcript |
| Human | MAP3K19 | 80122 | BC034417 | NM_025052 |
| About the gene | |
| Official Symbol | MAP3K19 |
| Previous Symbol | YSK4 |
| Official Full Name | mitogen-activated protein kinase kinase kinase 19 |
| Synonyms | FLJ23074; RCK |
| Location | 2q21.3 |
| Gene Type | protein-coding gene |
| Uniprot ID | Q56UN5 |
| Pathway/Library | Kinases Library |
| Gene Summary | MAP3K19 (also referred also as RCK and YSK-4) is a conserved stress-induced protein, which is upregulated in alveolar and interstitial macrophages, bronchial epithelial cells, and type II pneumocytes in COPD and IPF. Mechanistically, MAP3K19 appears to modulate TGF-beta signaling via the translocation (or shuttling) of activated Smad2 and Smad3 into the cell nucleus8. In a mouse model of smoke-induced emphysema, both an anti-MAP3K19 siRNA and a small-molecule inhibitor directed at this MAPK inhibited inflammation and improved airspace integrity. Targeting MAP3K19 also strongly inhibited bleomycin-induced pulmonary fibrosis when administered either prophylactically or therapeutically. MAP3K19 was required for IPF myofibroblast differentiation, and targeting its activity attenuated the profibrotic activity of these cells both in vitro and in an adoptive transfer SCID model of pulmonary fibrosis. |
| 产品编号 | 产品名称 | 包装 |
| L15891 | MAP3K19 Knockout Lentivirus | 108 TU |
| — | 说明书 | 1份 |
-80℃保存，至少一年有效。
注意事项：碧云天拥有sgRNA序列的知识产权，如果需要sgRNA序列，请在订购后发送邮件向info@beyotime.com索取。sgRNA序列信息与本慢病毒，未经碧云天书面许可不得用于任何商业用途，也不得移交给订货人所在实验室外的任何个人或单位。使用者在发表研究论文或结果时，应注明来源。
对于非目录产品的CRISPR基因敲除用的慢病毒的定制，可联系碧云天技术服务service@beyotime.com。
本产品仅限于专业人员的科学研究用，不得用于临床诊断或治疗，不得用于食品或药品，不得存放于普通住宅内。
为了您的安全和健康，请穿实验服并戴一次性手套操作。
| 产品编号 | 产品名称 | 包装 |
| L00015 | Control Knockout Lentivirus | 108 TU |
| L00017 | GFP Knockout Lentivirus | 108 TU |
| C0222 | 青霉素-链霉素溶液(100X) | 100ml |
| C0351-1ml | Polybrene (Hexadimethrine Bromide) | 1ml |
| C0351-50mg | Polybrene (Hexadimethrine Bromide) | 50mg |
| D0508S/M | 基因组编辑突变检测试剂盒 | 25/100次 |
| D7080S/M/L | T7 Endonuclease I (CRISPR等基因突变鉴定用) | 250/1250/5000U |
| ST551-10mg | Puromycin Dihydrochloride (嘌呤霉素) | 10mg/ml×1ml |
| ST551-50mg | Puromycin Dihydrochloride (嘌呤霉素) | 10mg/ml×5ml |
| ST551-250mg | Puromycin Dihydrochloride (嘌呤霉素) | 250mg |
| ST1380-500mg | Polybrene (≥94%, Reagent grade) | 500mg |
| ST1380-2g | Polybrene (≥94%, Reagent grade) | 2g |
| ST1380-10g | Polybrene (≥94%, Reagent grade) | 10g |
微信在线咨询
